Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage

NCT01916928 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT01916928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01916928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
Lead sponsor
Medstar Health Research Institute
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2014
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating cell free fetal dna, intrauterine fetal demise, miscarriage